MiNK Reports Second Quarter 2024 Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
MiNK Therapeutics, Inc. (INKT) Tops Q2 EPS by 3c
August 13, 2024 7:06 AM EDTMiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q2 EPS of ($0.07), $0.03 better than the analyst estimate of ($0.10).
For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.
... More


